» Articles » PMID: 37971134

Use of the Oswestry Disability Index in Ankylosing Spondylitis

Overview
Specialty General Medicine
Date 2023 Nov 16
PMID 37971134
Authors
Affiliations
Soon will be listed here.
Abstract

Objective: The Oswestry Disability Index is considered the gold standard in the evaluation of disability in patients with chronic mechanical back pain. The aim of this study was to assess the applicability of Oswestry Disability Index in patients with ankylosing spondylitis and its relationship with disease assessment parameters for ankylosing spondylitis.

Methods: A total of 100 patients diagnosed with ankylosing spondylitis were included in the study group. The control group consisted of 50 individuals with nonspecific low back pain. The Oswestry Disability Index and Bath Ankylosing Spondylitis Disease Activity Index were applied to both groups. In addition, the Visual Analog Scale, the Ankylosing Spondylitis Disease Activity Score C-Reactive Protein, the Ankylosing Spondylitis Disease Activity Score-the Erythrocyte Sedimentation Rate, the Bath Ankylosing Spondylitis Functional Index, Bath Ankylosing Spondylitis Metrology Index, and the Ankylosing Spondylitis Quality of Life scales were applied in the study group. the Erythrocyte Sedimentation Rate, C-Reactive Protein levels, and HLA-B27 analysis were noted as laboratory markers in ankylosing spondylitis patients.

Results: The scores of Oswestry Disability Index had a significant correlation with scores of Bath Ankylosing Spondylitis Disease Activity Index in ankylosing spondylitis patients (r=0.543) and in the control group (r=0.401). There was a significant correlation between the scores of Oswestry Disability Index and the Bath Ankylosing Spondylitis Functional Index (r=0.544), Bath Ankylosing Spondylitis Metrology Index (r=0.317), the Ankylosing Spondylitis Quality of Life (r=0.723), the Ankylosing Spondylitis Disease Activity Score-the Erythrocyte Sedimentation Rate (r=0.501), the Ankylosing Spondylitis Disease Activity Score C-Reactive Protein (r=0.530), Visual Analog Scale-Rest (r=0.476), and Visual Analog Scale-Activity (r=0.441) values in patients with ankylosing spondylitis.

Conclusion: Evaluation of Oswestry Disability Index in conjunction with Bath Ankylosing Spondylitis Disease Activity Index may warn the physician to interpret high Bath Ankylosing Spondylitis Disease Activity Index scores in the context of mechanical pain. Therefore, the use of Oswestry Disability Index in patients with ankylosing spondylitis will be beneficial.

Citing Articles

Ayurvedic management of recurrent lumbar pain, disability, and leg pain after posterior decompression with transforaminal lumbar interbody fusion in prolapsed intervertebral disc: A case report.

Kulkarni S, Kulkarni P J Ayurveda Integr Med. 2025; 16(1):101071.

PMID: 39823925 PMC: 11786815. DOI: 10.1016/j.jaim.2024.101071.

References
1.
Duruoz M, Doward L, Turan Y, Cerrahoglu L, Yurtkuran M, Calis M . Translation and validation of the Turkish version of the Ankylosing Spondylitis Quality of Life (ASQOL) questionnaire. Rheumatol Int. 2013; 33(11):2717-22. DOI: 10.1007/s00296-013-2796-y. View

2.
Gu X, Zhu W, He H, Wang Z, Ding S, Guo G . Efficacy and safety of percutaneous transforaminal endoscopic discectomy in the treatment of lumbar spinal stenosis combined with osteoporosis. Rev Assoc Med Bras (1992). 2019; 65(6):779-785. DOI: 10.1590/1806-9282.65.6.779. View

3.
Ward M . Outcomes in ankylosing spondylitis: what makes the assessment of treatment effects in ankylosing spondylitis different?. Ann Rheum Dis. 2006; 65 Suppl 3:iii25-8. PMC: 1798377. DOI: 10.1136/ard.2006.058461. View

4.
Machado P, Landewe R, van der Heijde D . Ankylosing Spondylitis Disease Activity Score (ASDAS): 2018 update of the nomenclature for disease activity states. Ann Rheum Dis. 2018; 77(10):1539-1540. DOI: 10.1136/annrheumdis-2018-213184. View

5.
Madsen O . Stability of fatigue, pain, patient global assessment and the Bath Ankylosing Spondylitis Functional Index (BASFI) in spondyloarthropathy patients with stable disease according to the Bath Ankylosing Spondylitis Disease Activity Index (BASDAI). Rheumatol Int. 2018; 38(3):425-432. DOI: 10.1007/s00296-017-3920-1. View